Himaja

  Once upon a time, there was a young individual who embarked on a journey to become a doctor. Their path was not initially driven by a burning passion, but rather by the loving encouragement of their mother. Despite this, as time went on, the young aspiring doctor began to fall in love with the captivating world of medicine. During their studies, the individual encountered a life-altering experience that shifted their perspective entirely. They faced an illness—a personal battle that forced them to confront their mortality and reevaluate the significance of the profession they had chosen. This profound encounter ignited a newfound appreciation for the healing power of medicine. However, it was not just the personal experience of illness that influenced their aspirations. Along their journey, the young doctor-to-be met a patient who touched their heart in a way no one else had. This special patient was fighting a fierce battle against cancer, and their unwavering spirit and resilience

In this blog, I'm cleverly jotting down all these fancy new terms I haven't quite mastered yet, ensuring they don't slip through the cracks of my memory. It's like a witty insurance policy against forgetfulness, allowing me to review and conquer them in the future. While browsing through Quora account, I came across an answer explaining why doctors do not prescribe Saridon tablets. According to the answer, the tablets contain a combination of drugs, including propyphenazone, which can potentially lead to Kounis syndrome . KOUNIS SYNDROME Kounis syndrome (KS) has been defined as cardiovascular symptoms that occur secondary to allergic or hypersensitivity insults. It was thought to be a rare condition but is now being more commonly identified as the cause of acute coronary events in patients without previous history of coronary artery disease (CAD). The most identified KS cases have been provoked by medications on elderly male patients. https://www.ncbi.nlm.nih.gov/pmc/ar

  ABSTRACT Giant Cell Tumor (GCT) is a rare, locally aggressive bone tumor that commonly affects young adults. The treatment of GCT often involves a multimodal approach, including surgical resection, adjuvant therapies, and, in some cases, targeted therapy. This case report describes the therapeutic modalities utilized in the management of a 26-year-old female with recurrent GCT. The patient underwent multiple surgeries, received denosumab treatment, and explored alternative Ayurvedic medications. Here, we present a case of recurrent GCT of the left distal femur in a young female and discuss the diagnostic challenges, treatment options, and the patient's response to unconventional therapy. INTRODUCTION Giant cell tumor (GCT) is one of the most common benign bone tumors, which occurs in young adults 20-40 years old with a high recurrence rate and a potential for aggressive behavior. [1]  It is most commonly located at the metaphyseal or epiphyseal portion of the tibia or femur. Whi